SCHEMBL18901136

SCHEMBL18901136

COc1ccc(F)c(CNI)c1F

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 3/20 0.41
▸ ROCK1 Q13464 2/20 0.41
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ KLKB1 P03952 4/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ HSP90B1 P14625 1/20 0.36
▸ TRAP1 Q12931 1/20 0.36
▸ HTR2A P28223 2/20 0.36
▸ HTR2C P28335 2/20 0.36
▸ HTR2B P41595 2/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ TUBB1 Q9H4B7 1/20 0.34
▸ KDM1A O60341 1/20 0.34
▸ MAOA P21397 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C8 P10632 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15983143 0.84 ROCK2 (0.42) ROCK2ROCK1MEN1KMT2AKLKB1
SCHEMBL17788616 0.79 MEN1 (0.40) ROCK2ROCK1MEN1KMT2AKLKB1
SCHEMBL15979348 0.79 GRIN2B (0.40) ROCK2ROCK1MEN1KMT2AKLKB1
SCHEMBL21346098 0.79 KDM1A (0.52) MEN1KMT2AL3MBTL1KDM1AMAOA
SCHEMBL14228558 0.77 HTR2A (0.39) ROCK2ROCK1MEN1KMT2AHSP90AA1
SCHEMBL24863725 0.77 ROCK2 (0.51) ROCK2ROCK1MEN1KMT2AKLKB1
SCHEMBL16447799 0.76 HSP90AA1 (0.40) ROCK2ROCK1MEN1KMT2AKLKB1
SCHEMBL4399022 0.76 ROCK2 (0.38) ROCK2ROCK1MEN1KMT2AHSP90AA1
SCHEMBL18216631 0.76 HTR2A (0.38) ROCK2ROCK1KLKB1HSP90AA1HSP90B1
SCHEMBL17221413 0.76 CD274 (0.46) HSP90AA1HSP90B1TRAP1HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3016951-B1 TRICYCLIC PYRIDO-CARBOXAMIDE DERIVATIVES AS ROCK INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-05-31 — — EP disclosed
Send feedback